搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Edwardsiella ictaluri 50S ribosomal protein L24 (rplX) CSB-YP513433EJO
CSB-EP513433EJO
CSB-BP513433EJO
CSB-MP513433EJO
CSB-EP513433EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Phosphoribosylglycinamide formyltransferase 2 (purT) CSB-YP513434EJO
CSB-EP513434EJO
CSB-BP513434EJO
CSB-MP513434EJO
CSB-EP513434EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Amino-acid acetyltransferase (argA) CSB-YP513435EJO
CSB-EP513435EJO
CSB-BP513435EJO
CSB-MP513435EJO
CSB-EP513435EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri 50S ribosomal protein L1 (rplA) CSB-YP513436EJO
CSB-EP513436EJO
CSB-BP513436EJO
CSB-MP513436EJO
CSB-EP513436EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Peptide chain release factor 3 (prfC), partial CSB-YP513437EJO
CSB-EP513437EJO
CSB-BP513437EJO
CSB-MP513437EJO
CSB-EP513437EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Recombination-associated protein RdgC (rdgC) CSB-YP513438EJO
CSB-EP513438EJO
CSB-BP513438EJO
CSB-MP513438EJO
CSB-EP513438EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Teredinibacter turnerae Protein-export protein SecB (secB) CSB-YP513439TLR
CSB-EP513439TLR
CSB-BP513439TLR
CSB-MP513439TLR
CSB-EP513439TLR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Teredinibacter turnerae ATP synthase gamma chain (atpG) CSB-YP513440TLR
CSB-EP513440TLR
CSB-BP513440TLR
CSB-MP513440TLR
CSB-EP513440TLR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Teredinibacter turnerae DNA replication and repair protein recF (recF) CSB-YP513441TLR
CSB-EP513441TLR
CSB-BP513441TLR
CSB-MP513441TLR
CSB-EP513441TLR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Teredinibacter turnerae Formamidopyrimidine-DNA glycosylase (mutM) CSB-YP513442TLR
CSB-EP513442TLR
CSB-BP513442TLR
CSB-MP513442TLR
CSB-EP513442TLR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Teredinibacter turnerae Prolipoprotein diacylglyceryl transferase (lgt), partial CSB-YP513443TLR1
CSB-EP513443TLR1
CSB-BP513443TLR1
CSB-MP513443TLR1
CSB-EP513443TLR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Teredinibacter turnerae Methylglyoxal synthase (mgsA) CSB-YP513444TLR
CSB-EP513444TLR
CSB-BP513444TLR
CSB-MP513444TLR
CSB-EP513444TLR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Teredinibacter turnerae 30S ribosomal protein S18 (rpsR) CSB-YP513445TLR
CSB-EP513445TLR
CSB-BP513445TLR
CSB-MP513445TLR
CSB-EP513445TLR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Teredinibacter turnerae Pyridoxine/pyridoxamine 5'-phosphate oxidase (pdxH) CSB-YP513446TLR
CSB-EP513446TLR
CSB-BP513446TLR
CSB-MP513446TLR
CSB-EP513446TLR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Teredinibacter turnerae UDP-N-acetylmuramoylalanine--D-glutamate ligase (murD) CSB-YP513447TLR
CSB-EP513447TLR
CSB-BP513447TLR
CSB-MP513447TLR
CSB-EP513447TLR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Teredinibacter turnerae Bis (5'-nucleosyl)-tetraphosphatase, symmetrical CSB-YP513448TLR
CSB-EP513448TLR
CSB-BP513448TLR
CSB-MP513448TLR
CSB-EP513448TLR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Teredinibacter turnerae Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp) CSB-YP513449TLR
CSB-EP513449TLR
CSB-BP513449TLR
CSB-MP513449TLR
CSB-EP513449TLR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Teredinibacter turnerae Carbamoyl-phosphate synthase small chain (carA) CSB-YP513450TLR
CSB-EP513450TLR
CSB-BP513450TLR
CSB-MP513450TLR
CSB-EP513450TLR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Teredinibacter turnerae DNA-directed RNA polymerase subunit beta (rpoB), partial CSB-YP513451TLR
CSB-EP513451TLR
CSB-BP513451TLR
CSB-MP513451TLR
CSB-EP513451TLR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Teredinibacter turnerae 50S ribosomal protein L23 (rplW) CSB-YP513452TLR
CSB-EP513452TLR
CSB-BP513452TLR
CSB-MP513452TLR
CSB-EP513452TLR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>